Shire plc

Shire plc - Andover, UK; parent of Shire companies; acquired Roberts Pharmaceutical Corp. in Dec, 1999, and BioChem Pharma in Dec. 2000; divested its vaccine business to ID Biomedical in April 2004; Shire acquired Transkaryotic Therapies, Inc. in April 2005 for ~$1.6 billion

Related product monographs:

1. EPO, rDNA/Amgen -- Parent
2. EPO, rDNA/TKT -- Intl. mark. ; Parent
3. Galactosidase, alfa, rDNA -- Intl. mark. ; Parent
4. Galactosidase, alpha/Genzyme rDNA -- Parent
5. Glucocerebrosidase, rDNA/Shire -- Intl. mark. ; Parent co.
6. Iduronidase, rDNA -- Parent
7. Iduronate-2-sulfatase, rDNA -- World mark. ; Parent
8. BCG Live/GSK -- Parent ; Former
9. Influenza vaccine/GSK Canada -- Parent ; Former
10. Skin, Cultured/Dermagraft -- World mark. ; Parent co.
11. Skin, Cultured/TransCyte -- Parent co. ; Former inv.
12. Icatibant -- World mark. ; Parent co.

Location - Andover UK FOR

Further information:
Description, ordering information, etc.
Order/Inquiry
Products Database

Copyright ©2020. Biotechnology Information Institute